QA: Allergan plc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001578845_2019_Allergan_plc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001578845, Allergan plc

  xvar xval
0 AssetsCurrent 6,475,400,000
1 IntangibleAssetsNetIncludingGoodwill 89,608,700,000
2 PropertyPlantAndEquipmentNet 1,787,000,000
3 remainder_Assets 3,916,500,000
4 LiabilitiesCurrent 5,727,900,000
5 LiabilitiesNoncurrent 882,000,000
6 remainder_Liabilities 30,046,700,000
7 CostOfGoodsAndServicesSold 2,191,400,000
8 SellingGeneralAndAdministrativeExpense 1,091,946,864
9 ResearchAndDevelopmentExpense 2,372,800,427
10 remainder_Expenses 16,567,952,647
11 remainder_Revenues 15,665,937,916
12 remainder_NetIncome -1,894,270,724
13 remainder_ComprehensiveNetIncome 2,945,156,079
  yvar yval
0 Assets 101,787,600,000
1 Liabilities 36,656,600,000
2 Expenses 22,224,099,938
3 Revenues 15,665,937,916
4 StockholdersEquity 65,131,000,000
5 NetIncome -8,452,432,746
6 ComprehensiveNetIncome -6,979,854,706
7 BaseVar 90,586,832,328
8 EconomicCapitalRatiobeforeLimitedLiability 1.95
9 EconomicCapitalRatio 2.99

Edgar->Model Mapping

Feature Distribution

Change over Time